General Information of the Compound
Compound ID
CP0170354
Compound Name
[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate
    Show/Hide
Synonyms
Diquafosol
Diquafosol [INN:BAN]
Diquafosol [INN]
INS-365
KPY 998
P1,P4-Bis(5'-uridyl) tetrahydrogen tetraphosphate
P1,P4-Bis(5'-uridyl) tetraphosphate
UppppU
[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate
    Show/Hide
Structure
Formula
C18H26N4O23P4
Molecular Weight
790.307
Canonical SMILES
O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2ccc(=O)[nH]c2=O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O
    Show/Hide
InChI
InChI=1S/C18H26N4O23P4/c23-9-1-3-21(17(29)19-9)15-13(27)11(25)7(41-15)5-39-46(31,32)43-48(35,36)45-49(37,38)44-47(33,34)40-6-8-12(26)14(28)16(42-8)22-4-2-10(24)20-18(22)30/h1-4,7-8,11-16,25-28H,5-6H2,(H,31,32)(H,33,34)(H,35,36)(H,37,38)(H,19,23,29)(H,20,24,30)/t7-,8-,11-,12-,13-,14-,15-,16-/m1/s1
    Show/Hide
InChIKey
NMLMACJWHPHKGR-NCOIDOBVSA-N
CAS
59985-21-6
Physicochemical Property
logP
-4.1902
Rotatable Bonds
14
Heavy Atom Count
49
Polar Areas
404.45
Hydrogen Bond Donor Count
10
Hydrogen Bond Acceptor Count
21
Complexity
49

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 148197
SID: 14913780
ChEMBL ID
CHEMBL221326
DrugBank ID
DB15919
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04714, P2Y purinoceptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  11
1
EC50 = 94.5 nM
   TI
   LI
   LO
   TS
2
EC50 = 100 nM
   TI
   LI
   LO
   TS
3
EC50 = 112 nM
   TI
   LI
   LO
   TS
4
EC50 = 145 nM
   TI
   LI
   LO
   TS
5
EC50 = 179 nM
   TI
   LI
   LO
   TS
6
EC50 = 210 nM
   TI
   LI
   LO
   TS
7
EC50 = 216 nM
   TI
   LI
   LO
   TS
8
EC50 = 231 nM
   TI
   LI
   LO
   TS
9
EC50 = 394 nM
   TI
   LI
   LO
   TS
10
EC50 = 419 nM
   TI
   LI
   LO
   TS
11
EC50 = 572 nM
   TI
   LI
   LO
   TS
Protein ID: PT05219, P2Y purinoceptor 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  1
1
EC50 = 130 nM
   TI
   LI
   LO
   TS
Protein ID: PT02796, P2Y purinoceptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  2
1
EC50 = 1160 nM
   TI
   LI
   LO
   TS
2
EC50 = 20000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Diquafosol )
Drug Name Diquafosol
Company Santen Pharmaceutical
Indication
Dry eye disease
Phase 3
Target(s)
P2Y purinoceptor 2 (P2RY2)
Agonist